About My Health Careers Internship MedBlogs Contact us
Medindia LOGIN REGISTER
Advertisement

BSI and Biogen Agrees to Develop New Therapies For Brain Disorders

by Medindia Content Team on September 26, 2007 at 5:55 PM
Font : A-A+

BSI and Biogen Agrees to Develop New Therapies For Brain Disorders

Johns Hopkins University's newly formed Brain Science Institute (BSI) and pharmaceutical development company Biogen Idec have agreed to collaborate on the development of new therapies for such neurodegenerative diseases as multiple sclerosis, Alzheimer's disease and Parkinson's disease.

The collaboration, which will run indefinitely, will be guided by a joint committee of representatives from Johns Hopkins and Biogen Idec. John Griffin, M.D., director of the BSI, will serve as the academic lead of the collaboration. He is a professor of neurology, neuroscience and pathology at Johns Hopkins and is the former director of the Johns Hopkins School of Medicine Department of Neurology. Griffin also is a longstanding participant in Biogen Idec's neurology scientific advisory board. The BSI is codirected by Rick Huganir, Ph.D., director of the Solomon Snyder Department of Neuroscience at Johns Hopkins.

Advertisement

The BSI was launched in March to speed the application of new discoveries to neurological diseases that currently have limited treatment options. Supported with a gift from an anonymous donor family, it brings together brain scientists from across the Hopkins schools and campuses to solve fundamental questions about brain development and function and to use these insights to understand the mechanisms of brain diseases, to develop effective treatments, and to take these therapies to patients.

"An important component of its mission is to foster translation of basic discovery into treatment," says Griffin, who is among the many Hopkins neuroscientists who collectively have more than 300 therapeutic and related patent applications. These inventions include candidate drugs for Alzheimer's disease and multiple sclerosis, novel cancer biomarkers, and a medical device for improved intracranial delivery of drugs.

The collaboration with the BSI would give Biogen Idec access to intellectual property to develop new neurological pharmaceuticals in exchange for research funding. Boards from both companies are expected to meet soon to select BSI projects to fund.

Source: John Hopkins
VEN/C
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Advertisement
News Category
What's New on Medindia
Turmeric: Magic Ingredient to Keep you Healthy in Winter
Top 7 Benefits of Good Oral Hygiene
Healthy and Safer Thanksgiving 2021
View all

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Parkinsons Disease Parkinsons Disease Surgical Treatment Brain Brain Facts Ataxia Language Areas in The Brain Ways to Improve your Intelligence Quotient (IQ) 

Recommended Reading
Alzheimers Disease
Alzheimer's disease is a progressive neurodegenerative disease affecting memory and thinking and ......
Parkinsons Disease
Parkinson's disease is a neurodegenerative disease caused by progressive dopamine brain cells loss. ...
Johns Hopkins Hospital Received "hospital of Choice" Award
The Johns Hopkins Hospital has again received the American Alliance of Healthcare Providers' (AAHP) ...
Ataxia
Ataxia affects coordination. Gait becomes unstable and the patient loses balance. The cerebellum or ...
Language Areas in The Brain
The mechanism of how human brain processes the language to express and comprehend the verbal, writte...
Ways to Improve your Intelligence Quotient (IQ)
Intelligence quotient (IQ) is a psychological measure of human intelligence. Regular physical and me...

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2021

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use